Mega Contracts Monitor ($100M+) — August 21, 2026

CACI won a $674.4M cost-plus-fixed-fee delivery order from GSA for IT/telecom services under the Communication and Information Technology Services III program, with a total potential of $722.6M. The cost-plus structure ensures stable margins, and full-and-open competition signals technical merit.

Teledyne Brown Engineering’s $371.5M NASA ISS mission support contract ended December 2022, with actual outlays of only $151.3M (41% of obligation), indicating under-execution. No follow-on or bridge awards are identified, creating a revenue gap.

The Albert B. Sabin Vaccine Institute received a $263.6M cost-plus-fixed-fee contract from BARDA for Marburg virus R&D, with a total potential of $1.04B. As a non-profit, direct equity exposure is nil, but subcontractors to publicly traded biotech firms may benefit.

HSGS-AMERESCO won a $149.2M firm-fixed-price delivery order from the VA for energy savings performance contracts at two VAMCs. Fixed-price structure shifts performance risk to the contractor, and the 19-month timeline (through Feb 2027) demands aggressive execution.

HIGHRISE Consulting secured a $138.6M labor-hours delivery order from NIH for IT/cloud support, with $89.6M already outlayed (65% utilization). The partial small business set-aside provides competitive protection but caps scalability.

CACI’s $674M GSA contract shows a negative net outlay of -$414,919, which is unusual and may indicate accounting adjustments or early-stage credits that could distort reported revenue.

HSGS-AMERESCO’s $149M VA ESPC is firm-fixed-price, meaning cost overruns or delays in energy savings verification could compress margins. The 19-month performance period is tight for construction/retrofit work.

Teledyne Brown’s $371.5M NASA contract has expired with no identified follow-on, creating a revenue cliff for the subsidiary. Only $151.3M of the obligation was outlayed, suggesting underperformance.

The Sabin Vaccine Institute’s $263.6M BARDA contract runs through 2036, exposing it to multi-year budget cycles and potential shifts in pandemic preparedness priorities under future administrations.

CACI’s $674M GSA IT contract and HIGHRISE’s $138.6M NIH cloud contract both point to sustained civilian agency IT modernization spending. Investors should overweight federal IT services contractors with cost-plus exposure.

Only 1 of 5 contracts is defense-related, suggesting a potential pivot toward civilian agencies. However, the lack of defense awards may signal CR-related delays; watch for DOD catch-up spending in Q4 FY2026.

HSGS-AMERESCO’s SDVOSB set-aside win highlights policy-driven opportunities in VA energy contracts. Investors should monitor small-cap SDVOSB-focused firms for similar VA ESPC awards.

Two contracts—CACI’s $674M GSA IT services and HIGHRISE’s $138.6M NIH cloud support—total $812M in civilian IT obligations, signaling robust demand for third-party IT and cloud services across GSA and NIH.

The Sabin Vaccine Institute’s $263.6M BARDA contract (potential $1.04B) underscores continued government commitment to Marburg virus and pandemic preparedness, though the non-profit recipient limits direct equity play.

Teledyne Brown’s expired $371.5M ISS support contract suggests NASA is transitioning to new operational models (e.g., commercial LEO destinations). No follow-on identified, indicating a potential shift away from legacy ISS support.

{"entity" => "CACI International Inc.", "reason" => "Negative net outlay on $674M GSA contract requires clarification; contract ends May 2024, so re-compete risk is imminent.", "trigger" => "CACI earnings call for contract profitability update; GSA re-compete announcement"}

{"entity" => "Teledyne Brown Engineering", "reason" => "Expired $371.5M NASA contract with no follow-on; revenue cliff for subsidiary.", "trigger" => "NASA ISS mission operations re-compete or commercial LEO station awards"}

{"entity" => "HSGS-AMERESCO, LLC", "reason" => "High fixed-price execution risk on $149M VA ESPC; 19-month timeline is aggressive.", "trigger" => "VA option exercise by Feb 2027; change order or cost overrun disclosure"}

{"entity" => "HIGHRISE CONSULTING INC", "reason" => "Strong 65% utilization on $138.6M NIH contract; watch for follow-on task orders.", "trigger" => "NIH IT budget allocations; new task order announcements under IDIQ"}

{"entity" => "Albert B. Sabin Vaccine Institute", "reason" => "Non-profit recipient limits direct equity; monitor subcontractor awards to public biotech firms.", "trigger" => "BARDA option exercise announcements; subcontract awards to public companies"}